BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang SY, Zhang Q, Casanova JL, Su HC; COVID Team. Severe COVID-19 in the young and healthy: monogenic inborn errors of immunity? Nat Rev Immunol 2020;20:455-6. [PMID: 32555547 DOI: 10.1038/s41577-020-0373-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 31] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 van der Made CI, Netea MG, van der Veerdonk FL, Hoischen A. Clinical implications of host genetic variation and susceptibility to severe or critical COVID-19. Genome Med 2022;14. [DOI: 10.1186/s13073-022-01100-3] [Reference Citation Analysis]
2 M M, F C, M G, S F, A B. How to: diagnose inborn errors of intrinsic and innate immunity to viral, bacterial, mycobacterial and fungal infections. Clinical Microbiology and Infection 2022. [DOI: 10.1016/j.cmi.2022.07.021] [Reference Citation Analysis]
3 Faist A, Janowski J, Kumar S, Hinse S, Çalışkan DM, Lange J, Ludwig S, Brunotte L. Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond. Cells 2022;11:2198. [DOI: 10.3390/cells11142198] [Reference Citation Analysis]
4 Redin C, Thorball CW, Fellay J. Host genomics of SARS-CoV-2 infection. Eur J Hum Genet 2022. [PMID: 35768520 DOI: 10.1038/s41431-022-01136-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Bastard P, Vazquez S, Liu J, Laurie MT, Wang CY, Gervais A, Le Voyer T, Bizien L, Zamecnik C, Philippot Q, Rosain J, Catherinot E, Willmore A, Mitchell AM, Bair R, Garçon P, Kenney H, Fekkar A, Salagianni M, Poulakou G, Siouti E, Sahanic S, Tancevski I, Weiss G, Nagl L, Manry J, Duvlis S, Arroyo-sánchez D, Paz Artal E, Rubio L, Perani C, Bezzi M, Sottini A, Quaresima V, Roussel L, Vinh DC, Reyes LF, Garzaro M, Hatipoglu N, Boutboul D, Tandjaoui-lambiotte Y, Borghesi A, Aliberti A, Cassaniti I, Venet F, Monneret G, Halwani R, Sharif-askari NS, Danielson J, Burrel S, Morbieu C, Stepanovskyy Y, Bondarenko A, Volokha A, Boyarchuk O, Gagro A, Neuville M, Neven B, Keles S, Hernu R, Bal A, Novelli A, Novelli G, Saker K, Ailioaie O, Antolí A, Jeziorski E, Rocamora-blanch G, Teixeira C, Delaunay C, Lhuillier M, Le Turnier P, Zhang Y, Mahevas M, Pan-hammarström Q, Abolhassani H, Bompoil T, Dorgham K, Gorochov G, Laouenan C, Rodríguez-gallego C, Ng LFP, Renia L, Pujol A, Belot A, Raffi F, Allende LM, Martinez-picado J, Ozcelik T, Keles S, Imberti L, Notarangelo LD, Troya J, Solanich X, Zhang S, Puel A, Wilson MR, Trouillet-assant S, Abel L, Jouanguy E, Ye CJ, Cobat A, Thompson LM, Andreakos E, Zhang Q, Anderson MS, Casanova J, Derisi JL, Abel L, Achille C, Aiuti A, Al-muhsen S, Al-mulla F, Anderson MS, Andreakos E, Angelini M, Arias AA, Aytekin G, Baldanti F, Feldman HB, Belot A, Bergami F, Biggs CM, Bogunovic D, Bolze A, Bondarenko A, Bousfiha AA, Brodin P, Bryceson Y, Bustamante CD, Butte MJ, Casari G, Christodoulou J, Condino-neto A, Constantinescu SN, Conti F, Cooper MA, Dalgard CL, Desai M, Drolet BA, El Baghdadi J, Ergun R, Ergun D, Espinosa-padilla S, Fellay J, Flores C, Franco JL, Froidure A, Ghirardello S, Gregersen PK, Grimbacher B, Haerynck F, Hagin D, Halwani R, Hammarström L, Heath JR, Henrickson SE, Hsieh EW, Husebye E, Imai K, Itan Y, Jarvis ED, Kanat F, Karamitros T, Kisand K, Kopcha V, Korda M, Ku C, Lau Y, Ling Y, Lucas CL, Maniatis T, Mansouri D, Maródi L, Meyts I, Milner JD, Mironska K, Mogensen TH, Mojoli F, Morandeira F, Morio T, Ng LF, Notarangelo LD, Novelli A, Novelli G, O'farrelly C, Okada S, Okamoto K, Ozcelik T, Pagani M, Pan-hammarström Q, Pape JW, de Diego RP, Perlin DS, Pesole G, Pession A, Piralla A, Planas AM, Prando C, Pujol A, Quintana-murci L, Ramaswamy S, Renia L, Resnick I, Rigo-bonnin R, Rodríguez-gallego C, Sancho-shimizu V, Sediva A, Seppänen MR, Shahrooei M, Shcherbina A, Slaby O, Snow AL, Soler-palacín P, Spaan AN, Tancevski I, Tangye SG, Abou Tayoun A, Tulek B, Turvey SE, Uddin KMF, Uddin M, Clément B, Abe-jones Y, Asthana S, Bhide S, Calfee CS, Carrillo SA, Chak S, Collins Z, Erle DJ, Fragiadakis GK, Ghale R, Hendrickson CM, Jauregui A, Kangelaris KN, Krummel MF, Langelier CR, Lea T, Lee D, Leligdowicz A, Leroux C, Lota R, Matthay M, Nguyen V, Patel R, Pierce L, Prasad P, Rao AA, Rashid A, Rodriguez N, Samad B, Shaw C, Sigman A, Tang K, Altamirano LT, Ward A, Willmore A, Wilson M, Woodruff PG, Abel L, Allavena C, Andrejak C, Angoulvant F, Azoulay C, Bachelet D, Bartoli M, Basmaci R, Behilill S, Beluze M, Benech N, Benkerrou D, Bhavsar K, Bitker L, Bouadma L, Bouscambert M, Paz PC, Cervantes-gonzalez M, Chair A, Chirouze C, Coelho A, Cordel H, Couffignal C, Couffin-cadiergues S, d’Ortenzio E, De Montmollin E, Debard A, Debray M, Deplanque D, Descamps D, Desvallée M, Diallo A, Diehl J, Diouf A, Dorival C, Dubos F, Duval X, Eloy P, Enouf V, Epaulard O, Esperou H, Esposito-farese M, Etienne M, Garot D, Gault N, Gaymard A, Ghosn J, Gigante T, Gilg M, Goehringer F, Guedj J, Hoctin A, Hoffmann I, Houas I, Hulot J, Jaafoura S, Kafif O, Kaguelidou F, Kali S, Kerroumi Y, Khalil A, Khan C, Kimmoun A, Laine F, Laouénan C, Laribi S, Le M, Le Bris C, Le Gac S, Le Hingrat Q, Le Mestre S, Le Nagard H, Lemaignen A, Lemee V, Lescure F, Letrou S, Levy Y, Lina B, Lingas G, Lucet JC, Machado M, Malvy D, Mambert M, Manuel A, Mentré F, Meziane A, Mouquet H, Mullaert J, Neant N, Nguyen D, Noret M, Papadopoulos A, Paul C, Peiffer-smadja N, Peigne V, Petrov-sanchez V, Peytavin G, Pham H, Picone O, Piquard V, Poissy J, Puéchal O, Rosa-calatrava M, Rossignol B, Rossignol P, Roy C, Schneider M, Su R, Tardivon C, Tellier M, Téoulé F, Terrier O, Timsit J, Tual C, Tubiana S, Van Der Werf S, Vanel N, Veislinger A, Visseaux B, Wiedemann A, Yazdanpanah Y; COVID HGE consortium, French COVID study group, COMET consortium. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs. Sci Immunol . [DOI: 10.1126/sciimmunol.abp8966] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Liu P, Fang M, Luo Y, Zheng F, Jin Y, Cheng F, Zhu H, Jin X. Rare Variants in Inborn Errors of Immunity Genes Associated With Covid-19 Severity. Front Cell Infect Microbiol 2022;12:888582. [DOI: 10.3389/fcimb.2022.888582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Youssry I, Abd Elaziz D, Ayad N, Eyada I. The Cause–Effect Dilemma of Hematologic Changes in COVID-19: One Year after the Start of the Pandemic. Hematology Reports 2022;14:95-102. [DOI: 10.3390/hematolrep14020014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Rubina K, Shmakova A, Shabanov A, Andreev Y, Borovkova N, Kulabukhov V, Evseev A, Popugaev K, Petrikov S, Semina E. Novel prognostic determinants of COVID-19-related mortality: A pilot study on severely-ill patients in Russia. PLoS One 2022;17:e0264072. [PMID: 35213582 DOI: 10.1371/journal.pone.0264072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Murray MF. Enabling Diagnostic Resulting as a New Category of Secondary Genomic Findings. JPM 2022;12:158. [DOI: 10.3390/jpm12020158] [Reference Citation Analysis]
10 Bastard P, Zhang Q, Zhang S, Jouanguy E, Casanova J. Type I interferons and SARS-CoV-2: from cells to organisms. Current Opinion in Immunology 2022. [DOI: 10.1016/j.coi.2022.01.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
11 Douillard V, Castelli EC, Mack SJ, Hollenbach JA, Gourraud PA, Vince N, Limou S; Covid-19|HLA & Immunogenetics Consortium and the SNP-HLA Reference Consortium. Current HLA Investigations on SARS-CoV-2 and Perspectives. Front Genet 2021;12:774922. [PMID: 34912378 DOI: 10.3389/fgene.2021.774922] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
12 Chu CF, Sabath F, Fibi-Smetana S, Sun S, Öllinger R, Noeßner E, Chao YY, Rinke L, Winheim E, Rad R, Krug AB, Taher L, Zielinski CE. Convalescent COVID-19 Patients Without Comorbidities Display Similar Immunophenotypes Over Time Despite Divergent Disease Severities. Front Immunol 2021;12:601080. [PMID: 34867933 DOI: 10.3389/fimmu.2021.601080] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Halawa S, Pullamsetti SS, Bangham CRM, Stenmark KR, Dorfmüller P, Frid MG, Butrous G, Morrell NW, de Jesus Perez VA, Stuart DI, O'Gallagher K, Shah AM, Aguib Y, Yacoub MH. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective. Nat Rev Cardiol 2021. [PMID: 34873286 DOI: 10.1038/s41569-021-00640-2] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
14 Schulert GS, Blum SA, Cron RQ. Host genetics of pediatric SARS-CoV-2 COVID-19 and multisystem inflammatory syndrome in children. Curr Opin Pediatr 2021;33:549-55. [PMID: 34534994 DOI: 10.1097/MOP.0000000000001061] [Reference Citation Analysis]
15 Espejo-Paeres C, Espliguero RA, Uribarri A, Antón-Huguet B, Romero R, Fernández-Rozas I, Becerra-Muñoz VM, Alfonso-Rodríguez E, Huang J, Ortega-Armas ME, Pepe M, González A, Bertolazzi M, Cerrato E, Quezada A, Raposeiras-Roubin S, Vedia O, Feltes-Guzmán G, Akin I, Carrero-Fernández A, Macaya C, Estrada V, Núñez-Gil IJ; HOPE COVID-19 investigators. Predictors of poor prognosis in healthy, young, individuals with SARS-CoV-2 infections. Clin Microbiol Infect 2021:S1198-743X(21)00545-0. [PMID: 34600119 DOI: 10.1016/j.cmi.2021.09.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Bötticher B, Dinkelbach L, Hillebrecht M, Adams O, Dechert O, Trocan L, Neubert J, Borkhardt A, Janßen G. High rate of clinically unrecognized SARS-CoV-2 infections in pediatric palliative care patients. Eur J Pediatr 2021. [PMID: 34467455 DOI: 10.1007/s00431-021-04242-5] [Reference Citation Analysis]
17 Apostolidou S, Harbauer T, Lasch P, Biermann D, Hempel M, Lütgehetmann M, Pfefferle S, Herrmann J, Rüffer A, Reinshagen K, Kozlik-Feldmann R, Gieras A, Kniep I, Oh J, Singer D, Ebenebe CU, Kobbe R. Fatal COVID-19 in a Child with Persistence of SARS-CoV-2 Despite Extensive Multidisciplinary Treatment: A Case Report. Children (Basel) 2021;8:564. [PMID: 34208887 DOI: 10.3390/children8070564] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Bastard P, Zhang Q, Cobat A, Jouanguy E, Zhang SY, Abel L, Casanova JL. Insufficient type I IFN immunity underlies life-threatening COVID-19 pneumonia. C R Biol 2021;344:19-25. [PMID: 34213846 DOI: 10.5802/crbiol.36] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Spinelli FR, Meylan F, O'Shea JJ, Gadina M. JAK inhibitors: Ten years after. Eur J Immunol 2021;51:1615-27. [PMID: 33930196 DOI: 10.1002/eji.202048922] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
20 Ku CL, Chen IT, Lai MZ. Infection-induced inflammation from specific inborn errors of immunity to COVID-19. FEBS J 2021;288:5021-41. [PMID: 33971084 DOI: 10.1111/febs.15961] [Reference Citation Analysis]
21 Monticelli M, Mele BH, Andreotti G, Cubellis MV, Riccio G. Why does SARS-CoV-2 hit in different ways? Host genetic factors can influence the acquisition or the course of COVID-19. Eur J Med Genet 2021;64:104227. [PMID: 33872774 DOI: 10.1016/j.ejmg.2021.104227] [Reference Citation Analysis]
22 Hetzel M, Ackermann M, Lachmann N. Beyond "Big Eaters": The Versatile Role of Alveolar Macrophages in Health and Disease. Int J Mol Sci 2021;22:3308. [PMID: 33804918 DOI: 10.3390/ijms22073308] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
23 Betti M, Bertolotti M, Ferrante D, Roveta A, Pelazza C, Giacchero F, Penpa S, Massarino C, Bolgeo T, Cassinari A, Mussa M, Chichino G, Maconi A. Baseline clinical characteristics and prognostic factors in hospitalized COVID-19 patients aged ≤ 65 years: A retrospective observational study. PLoS One 2021;16:e0248829. [PMID: 33760885 DOI: 10.1371/journal.pone.0248829] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
24 Naslavsky MS, Vidigal M, Matos LDRB, Cória VR, Batista Junior PB, Razuk Á, Saldiva PHN, Dolhnikoff M, Schidlowski L, Prando C, Cunha-Neto E, Condino-Neto A, Passos-Bueno MR, Zatz M. Extreme phenotypes approach to investigate host genetics and COVID-19 outcomes. Genet Mol Biol 2021;44:e20200302. [PMID: 33651876 DOI: 10.1590/1678-4685-GMB-2020-0302] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
25 Kosmicki JA, Horowitz JE, Banerjee N, Lanche R, Marcketta A, Maxwell E, Bai X, Sun D, Backman JD, Sharma D, Kang HM, O'Dushlaine C, Yadav A, Mansfield AJ, Li AH, Watanabe K, Gurski L, McCarthy SE, Locke AE, Khalid S, O'Keeffe S, Mbatchou J, Chazara O, Huang Y, Kvikstad E, O'Neill A, Nioi P, Parker MM, Petrovski S, Runz H, Szustakowski JD, Wang Q, Wong E, Cordova-Palomera A, Smith EN, Szalma S, Zheng X, Esmaeeli S, Davis JW, Lai YP, Chen X, Justice AE, Leader JB, Mirshahi T, Carey DJ, Verma A, Sirugo G, Ritchie MD, Rader DJ, Povysil G, Goldstein DB, Kiryluk K, Pairo-Castineira E, Rawlik K, Pasko D, Walker S, Meynert A, Kousathanas A, Moutsianas L, Tenesa A, Caulfield M, Scott R, Wilson JF, Baillie JK, Butler-Laporte G, Nakanishi T, Lathrop M, Richards JB, Jones M, Balasubramanian S, Salerno W, Shuldiner AR, Marchini J, Overton JD, Habegger L, Cantor MN, Reid JG, Baras A, Abecasis GR, Ferreira MA. A catalog of associations between rare coding variants and COVID-19 outcomes. medRxiv 2021:2020. [PMID: 33655273 DOI: 10.1101/2020.10.28.20221804] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
26 Marcus N, Frizinsky S, Hagin D, Ovadia A, Hanna S, Farkash M, Maoz-Segal R, Agmon-Levin N, Broides A, Nahum A, Rosenberg E, Kuperman AA, Dinur-Schejter Y, Berkun Y, Toker O, Goldberg S, Confino-Cohen R, Scheuerman O, Badarneh B, Epstein-Rigbi N, Etzioni A, Dalal I, Somech R. Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel. Front Immunol 2020;11:614086. [PMID: 33519822 DOI: 10.3389/fimmu.2020.614086] [Cited by in Crossref: 12] [Cited by in F6Publishing: 44] [Article Influence: 12.0] [Reference Citation Analysis]
27 Fragala MS, Goldberg ZN, Goldberg SE. Return to Work: Managing Employee Population Health During the COVID-19 Pandemic. Popul Health Manag 2021;24:S3-S15. [PMID: 33347795 DOI: 10.1089/pop.2020.0261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
28 Piroth L, Cottenet J, Mariet AS, Bonniaud P, Blot M, Tubert-Bitter P, Quantin C. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. Lancet Respir Med 2021;9:251-9. [PMID: 33341155 DOI: 10.1016/S2213-2600(20)30527-0] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 33.5] [Reference Citation Analysis]
29 Brandão‐de‐resende C, Diniz‐filho A, Almeida Brito F, Vasconcelos‐santos DV. SARS‐CoV‐2 and COVID‐19 for the ophthalmologist. Clin Experiment Ophthalmol 2021;49:70-80. [DOI: 10.1111/ceo.13877] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Borocco C, Pouletty M, Galeotti C, Meinzer U, Faye A, Koné-Paut I, Ouldali N, Melki I. Response to 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID19): a multicentre cohort'' by Mastrolia et al. Ann Rheum Dis 2020:annrheumdis-2020-218814. [PMID: 33023959 DOI: 10.1136/annrheumdis-2020-218814] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
31 Mulinari Turin de Oliveira N, Fernandes da Silva Figueiredo I, Cristine Malaquias da Silva L, Sauruk da Silva K, Regis Bueno L, Barbosa da Luz B, Rita Corso C, de Paula Werner MF, Soares Fernandes E, Maria-Ferreira D. Tissue Proteases and Immune Responses: Influencing Factors of COVID-19 Severity and Mortality. Pathogens 2020;9:E817. [PMID: 33036180 DOI: 10.3390/pathogens9100817] [Cited by in F6Publishing: 2] [Reference Citation Analysis]